endolinx Medical News about Type 2 Diabetes

Click the title below to leave the MDLinx Network and go to the Journal's Website

Targeting beta-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins
Endocrine Reviews, 05/15/08

Email This Article

Save in My Library

Free Abstract

Salehi M et al. - Incretin-based drugs hold the potential to improve glucose tolerance by immediate favorable effect on beta-cell physiology as well as by expanding or at least maintaining beta-cell mass, which may delay the progression of the disease. Long-term studies in humans are needed to elaborate on these effects.

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

The Correlation of Insulin Resistance With Serum Tumor Necrosis Factor-Alpha Levels in Patients With Rheumatoid Arthritis
The Endocrinologist, 07/18/08

Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes
Endocrinology and Metabolism, 08/07/08

Expression of IGF-II and its receptor in pediatric and adult adrenocortical tumors
Journal of Clinical Endocrinology and Metabolism, 07/09/08

...All of Basic Science/Genetics

Sponsor

--- DIABETES TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

A novel insulin formulation with a more rapid onset of action
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 07/22/08

Heeding clues to metformin-associated lactic acidosis: prompt response can save life
Emergency Medicine Journal, 07/28/08

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?
Diabetes Care, 07/30/08

...All of Diabetes